Presentations and Articles

“License Compliance Issues for Biopharmaceuticals: Special Challenges for Negotiations between Companies and Non-Profit Research Institutions” Todd A. Ponzio, Ph.D., Hans Feindt, Ph.D. & Steven M. Ferguson, CLP, les Nouvelles, Volume XLVI No. 3 pp. 216-225 (September 2011).
“Research Discoveries after Kubin” Nancy W. Vensko, JD, and Steven M. Ferguson, MBA, CLP, AUTM Technology Transfer Practices Manual, 3rd Edition, Volume 4, Part I, pp 1-20 (2010)
“Research Tools Policies and Practices: Perspective of a Public Institution” Uri Reichman, PhD, MBA, Susan E. Ano, PhD, and Steven M. Ferguson, MBA, CLP, AUTM Technology Transfer Practices Manual, 3rd Edition, Volume 4, pp 1-29 (2010)
“The Role of Public-Sector Research in the Discovery of Drugs and Vaccines” Ashley J. Stevens, Jonathan J. Jensen, Katrine Wyller, Patrick C. Kilgore, Sabarni Chatterjee, and Mark L. Rohrbaugh; N Engl J Med. 2011 Feb 10;364:535-541.
“Biotechnology Entrepreneurship: From Science to Solutions” Chapter 7 – Licensing and Technology Transfer, Steven M. Ferguson, CLP and Ruchika Nijhara, Ph.D. MBA, Logos Press (2010)
Commercial Licensing of HIV-1 Protease: Applications of the NIH Research Tools Policy George H. Keller and Steven M. Ferguson
Tomorrow's Technology Transfer (AUTM) vol 2, no 1 Winter-Spring-2010 Research Discoveries after Kubin Nancy W. Vensko, JD and Steven M. Ferguson, MBA, CLP
Technology Transfer at the National Institutes of Health "Technology Transfer in Biotechnology" Mark L. Rohrbaugh and Brian R. Stantion
Partnerships for Global Vaccine Development Rotavirus Vaccine Kevin Chang, Ph.D.; Peter Soukas, J.D.; Susan Ano, Ph.D. and Uri Reichman, Ph.D.   CSTA Industry Forum, Bethesda, MD, February 17-18, 2010
"Intellectual Property And Other Contractual Issues In Cooperative Research And Development Agreements (CRADAs): Part II" By Matthew W. Sagal, Gene Slowinski, Kenneth Freese and Steven Ferguson
Case Study: Typhoid Vaccine
Case Study: Rotavirus Vaccine
“Intellectual Property and Other Issues in Cooperative Research and Development Agreements (CRADAs): Part I” Matthew W. Sagal, Gene Slowinski, Kenneth Freese and Steven Ferguson, les Nouvelles, Volume XIV, No.1 pp. 41-48e (March 2009).
"NIH Offers Licensing Agreements to Commercialize Technologies" Mark L. Rohrbaugh, PhD. BioPharm International. 2008 March; Volume 20, issue 3, pp. 60-66.
“PRINCIPLES AND PRACTICE OF CLINICAL RESEARCH” Jack Spiegel, PhD. (2008)
“Transfer and Valuation of Biomedical Intellectual Property” Cristina Thalhammer-Reyero. Chapter 22 from Taxation and Valuation of Technology: Theory, Practice, and the Law, James Horvath and David Chodikoff, editors. Irwin Law Inc. (2008)
“Biopharmaceutical Research Collaborations between India and the West: A Guide to Prospective Partnerships” Uri Reichman, Bharat Khurana, and Steven M. Ferguson. Chapter 18 from Advances in Biopharmaceutical Technology in India, pp 661-722 (2008)
“Administration of Technology Licenses” Hans H. Feindt, Chapter 15.1 from Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (2007).
“Knowledge and Technology Mobilization to Advance Public Health: An NIH Perspective” Jack Spiegel, in Intellectual Property at the Edge: New Approaches to IP in a Transsystemic World, Proceedings of the Meredith Lectures, Editor Yvon Blais (2007).
“Biopharmaceutical Research Collaboration between Western and Chinese Life Science Organizations: A Guide to Prospective Partnerships” Steven M. Ferguson, Sally H. Hu and Uri Reichman, Chapter 19 from Advances in Biopharmaceutical Technology in China, pp 935-1017 (2006)
“Avoiding the Avalanche: Records Management Techniques for Improving Workflow in Technology Transfer Offices” David R. Sadowski, AUTM Technology Transfer Practice Manual 3rd Edition, Volume 2 Part 1, Chapter 8.3 (2006).
Building a Business - "Beyond Patents and Royalties: the Perception and Reality of Doing Business with the NIH" Gil Ben-Menachem, Steven M Ferguson & Krishna Balakrishnan, Nature Biotechnology Volume 24 Number 1 (January 2006).
"Partnerships in Technology Transfer", An Innovative Program to Move Biomedical and Health Technologies from the Laboratory to Worldwide Application Luis A Salicrup, Rachelle F Harris and Mark L Rohrbaugh, ISPT-12-2005
"Bypassing Bypass Surgery and Other Success Stories from the National Institutes of Health" Ruchika Nijhara, J. Lille Tidwell, Steven M. Ferguson, and Krishna Balakrishnan, Journal of the Association of University Technology Managers, vol 17 no 2 pp 1-16 (Fall 2005)
"Technology Marketing - Strategies and Tools That Work" - Licensing Executive Society (LES) Annual Meeting (October 2005).
"Effective strategies for marketing biomedical inventions: Lessons learnt from NIH licence leads" V.Ramakrishnan, J. Chen, K. Balakrishnan (October 2005)
"Technology Transfer & Disruptive Innovation at NIH: The Case of Taxus ExpressTM" -- Technology Transfer Society Annual Meeting (September 2005).
"Developing Products For Personalized Medicine: NIH Research Tools Applications" - IBC's 4th Annual Conference on Molecular Diagnostics and Personalized Medicine (September 2005).
"Nature's Medicines: Traditional Knowledge and Intellectual Property Management. Case Studies from the National Institutes of Health (NIH), USA" Ranjan Gupta, Bjarne Gabrielsen and Steven M. Ferguson, Current Drug Discovery Technologies, vol 2, pp 203-219 (2005).
"Developing Products for Personalized medicine: NIH Research Tool Policy Applications" Ranjan Gupta, JP Kim, Jack Speigel & Steven M Ferguson 1(1) pp115-124 (2004)
Practical Application - "Monitoring of Biomedical License Agreements- A Practical Guide George H. Keller, Steven M Ferguson and Percy Pan, Journal PDR 2003 1 (3) pp191-203
DDT - "Distribution and Licensing of Drug Discovery Tools - NIH Perspectives" Steven M Ferguson vol 7 No 21 (November 2002)
"Clinical Evaluation" Steven M Ferguson (Japan 2002)
Products, Partners & Public Health - "Transfer of Biomedical Technologies from the U.S. Government" Steven M Ferguson, V5 Number 2 (2002)
"Licensing and Distribution of Research Tools: National Institutes of Health Perspective" Steven M Ferguson, Journal of Clinical Pharmacology, vol 41, pp 107S-117S (July 2001 Supplement).
“Panel Report of the Forum on Sponsored Research Agreements: Perspectives, Outlook, and Policy Development (May 1994)” Steven M. Ferguson